Organon has in recent times elected to focus more on its women’s health biopharma portfolio, as reflected by the divestment of its JADA post-partum haemorrhage system in 2025. Image credit: testing ...

Abbott has touted the potential of its neuromodulation portfolio in reducing patient and healthcare burdens associated with ...

Myra Vision has enrolled the first patient in the ADAPT clinical trial assessing its Calibreye TGT surgical system in the US, ...

The medtech giant achieved FY25 revenues of $25.1bn, representing an 11.2% rise on FY24 at $22.59bn. Releasing its financial results after market close on 29 January, Stryker’s shares on the New York ...

RevBio has received the FDA investigational device exemption (IDE) approval to conduct a clinical trial of its cranial flap ...

Oath Surgical is collaborating with NVIDIA to advance the artificial intelligence (AI) capabilities of the OathOS platform ...

KORU Medical Systems has received the US FDA 510(k) clearance to use its FreedomEDGE infusion system for administering Rystiggo.

Boston Scientific has shared a range of data highlighting the benefits of spinal cord stimulation (SCS) therapies within its ...

HighLife has received CE mark approval for its TMVR system, allowing commercialisation across Europe for adult patients with ...

A new report has revealed that 83% of life sciences CEOs view Internet of Medical Things (IoMT) devices as the most important ...

SamanTree Medical has received a €20m ($23.7m) grant from the European Investment Bank (EIB) to advance the commercial ...

Recent developments in reimbursement and insurer coverage for plaque analysis in the US are a step towards the evaluative ...